Device Trial Radar · NCT00821236
Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK
Last checked: Nov 20, 2026Latest source record: Mar 1, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jan 2009
Primary completion
Feb 2010
Study completion Feb 2010
Sponsor
- Lead sponsor
- Durrie VisionAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Alcon Research
- First posted
- Jan 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare LASIK outcomes using the WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment. Standard refractive outcomes such as uncorrected and best corrected visual acuity, and intended vs. achieved postoperative refractions will be evaluated; in addition, high order optical aberrations, contrast sensitivity, and topography will be measured.
Conditions
- Myopia
- Astigmatism
Interventions
Excimer LaserDevice
WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment
AMO/VISX CustomVue™Device
Excimer Laser
LADARVision 4000 excimer laserDevice
Excimer Laser
Primary outcomes
What the sponsor says the trial is designed to measure.
- 1 Day Postoperative Lasik Uncorrected Visual AcuityTime frame: 1 Day
- 1 Week Postoperative Lasik Uncorrected Visual AcuityTime frame: 1 week post op
- 1 Month Postoperative Lasik Visual AcuityTime frame: 1 Month Postoperative
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Durrie Vision
Overland Park, Kansas
Karl G. Stonecipher, MD
Greensboro, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.